Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Rheumatology"
DOI: 10.1007/s10067-020-04956-1
Abstract: Introduction/objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This post-hoc analysis evaluated the effect of temporary discontinuation and reinitiation of tofacitinib on disease control in patients with RA… read more here.
Keywords: treatment; efficacy; efficacy tofacitinib; sub study ... See more keywords
Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
Sign Up to like & getrecommendations! Published in 2020 at "RMD Open"
DOI: 10.1136/rmdopen-2019-001042
Abstract: Objective To describe the efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) or ankylosing spondylitis (AS) in a post-hoc analysis of randomised controlled trials. Methods Data were collected… read more here.
Keywords: ankylosing spondylitis; efficacy tofacitinib; tofacitinib reducing; arthritis ... See more keywords
The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2022.820586
Abstract: JAK-inhibitors are small molecules blocking the JAK-STAT pathway that have proven effective in the treatment of different immune-mediated diseases in adults and juvenile idiopathic arthritis (JIA). Aim of Study To evaluate the safety and efficacy… read more here.
Keywords: rheumatic diseases; efficacy tofacitinib; pediatric rheumatic; safety efficacy ... See more keywords